X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
index medicus (9) 9
animals (6) 6
cell line, tumor (6) 6
lung neoplasms - genetics (6) 6
mice (6) 6
oncology (6) 6
gene amplification (5) 5
tumors (5) 5
cancer (4) 4
lung neoplasms - drug therapy (4) 4
lung neoplasms - pathology (4) 4
mutations (4) 4
carcinoma, non-small-cell lung - genetics (3) 3
female (3) 3
gene (3) 3
lung cancer (3) 3
male (3) 3
receptor, fibroblast growth factor, type 1 - genetics (3) 3
signal transduction - drug effects (3) 3
acquired-resistance (2) 2
activation (2) 2
adenocarcinoma (2) 2
adenocarcinoma of lung (2) 2
antineoplastic agents - pharmacology (2) 2
apoptosis - drug effects (2) 2
cell lines (2) 2
cell proliferation - drug effects (2) 2
crizotinib (2) 2
development and progression (2) 2
disease models, animal (2) 2
expression (2) 2
family (2) 2
fibroblast growth factor (2) 2
fibroblast growth factor receptor 1 (2) 2
fibroblast growth factor receptors (2) 2
gefitinib (2) 2
gene expression profiling (2) 2
genetic aspects (2) 2
genomics (2) 2
heterografts (2) 2
identification (2) 2
lung neoplasms - diagnosis (2) 2
lung neoplasms - metabolism (2) 2
map kinase (2) 2
middle aged (2) 2
multidisciplinary sciences (2) 2
nih 3t3 cells (2) 2
oncogene proteins, fusion - genetics (2) 2
oncogene proteins, fusion - metabolism (2) 2
receptor, fibroblast growth factor, type 1 - antagonists & inhibitors (2) 2
receptor, fibroblast growth factor, type 1 - metabolism (2) 2
small cell lung carcinoma (2) 2
small cell lung carcinoma - genetics (2) 2
transcription (2) 2
treatment outcome (2) 2
xenograft model antitumor assays (2) 2
adenocarcinoma - genetics (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma, mucinous - genetics (1) 1
adenocarcinoma, mucinous - pathology (1) 1
adult (1) 1
advanced solid tumors (1) 1
aged (1) 1
aged, 80 and over (1) 1
akt (1) 1
akt protein (1) 1
alk (1) 1
alterations (1) 1
amplification (1) 1
anaplastic lymphoma kinase (1) 1
angiogenesis (1) 1
angiogenesis inhibitors - pharmacology (1) 1
antigens, differentiation, b-lymphocyte - genetics (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - pharmacology (1) 1
apoptosis (1) 1
article (1) 1
aurora kinase b (1) 1
aurora kinases (1) 1
aurora-b kinase (1) 1
autocrine signalling (1) 1
base sequence (1) 1
basic biological sciences (1) 1
beer (1) 1
benzamides - pharmacology (1) 1
benzamides - therapeutic use (1) 1
bgj398 (1) 1
biochemistry (1) 1
biochemistry & molecular biology (1) 1
biological science (1) 1
biological sciences (1) 1
biomarkers, tumor (1) 1
biotechnology (1) 1
breast cancer (1) 1
breast neoplasms - pathology (1) 1
breast-cancer (1) 1
c-met protein (1) 1
carcinoma, neuroendocrine - genetics (1) 1
carcinoma, non-small-cell lung - drug therapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2012, Volume 109, Issue 42, pp. 17034 - 17039
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 1048 - 13
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 2954 - 2954
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2017, Volume 23, Issue 18, pp. 5527 - 5536
Purpose: The 8p12-p11 locus is frequently amplified in squamous cell lung cancer (SQLC); the receptor tyrosine kinase fibroblast growth factor receptor 1... 
DOSE-ESCALATION | SELECTIVE INHIBITOR | GEFITINIB | POTENT | ADVANCED SOLID TUMORS | AMPLIFICATION | ONCOLOGY | ACQUIRED-RESISTANCE | CRIZOTINIB | PHASE-I | RECEPTOR TYROSINE KINASE | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Translocation, Genetic | Membrane Proteins - genetics | Humans | Proto-Oncogene Proteins c-met | Tomography, X-Ray Computed | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Biomarkers, Tumor | Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Animals | Gene Amplification | GTP Phosphohydrolases - genetics | Cell Line, Tumor | Protein Binding | Antineoplastic Agents - pharmacology | Mice | Protein Kinase Inhibitors - pharmacology | Lung Neoplasms - diagnosis | Disease Models, Animal | Fibroblast growth factor | Biotechnology | Transcription | Lung cancer | Activation | Drug resistance | Drug development | c-Met protein | Clonal deletion | Deletion | Protein-tyrosine kinase receptors | Inhibition | Fibroblast growth factor receptor 1 | Protein-tyrosine kinase | Tyrosine | Subpopulations | Tumor cells | MAP kinase | Shrinkage | Tumor cell lines | Amplification | Inhibitors | Experimental design | Cell lines | Chromosome 8 | Viability | Tumors | Cancer | Fibroblast growth factor receptors
Journal Article
Oncogene, ISSN 0950-9232, 10/2018, Volume 37, Issue 42, pp. 5682 - 5693
FGFR1 amplification has been found in 15% of patients with breast cancer and has been postulated as a promising marker to predict response against FGFR... 
CARCINOMA-CELLS | SURVIVAL | ACTIVATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | BGJ398 | ACQUIRED-RESISTANCE | RECEPTOR | AKT | TUMORS | CELL BIOLOGY | ONCOLOGY | GROWTH | GENETICS & HEREDITY | Vascular Endothelial Growth Factor Receptor-1 - antagonists & inhibitors | Humans | Neovascularization, Pathologic | Angiogenesis Inhibitors - pharmacology | Pyrimidines - pharmacology | Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors | Quinolines - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Naphthalenes - pharmacology | Drug Synergism | Animals | Heterografts | Piperidines - pharmacology | Breast Neoplasms - pathology | Cell Line, Tumor | Female | Mice, Inbred NOD | Mice | Phenylurea Compounds - pharmacology | Quinazolines - pharmacology | Molecular targeted therapy | Care and treatment | Gene amplification | Innovations | Development and progression | Breast cancer | Genetic aspects | Growth factor receptors | Health aspects | Cell proliferation | Fibroblast growth factor | Phosphorylation | Secretion | Clinical trials | Extracellular signal-regulated kinase | MAP kinase | AKT protein | Patients | Vascular endothelial growth factor receptors | Angiogenesis | Autocrine signalling | Fibroblast growth factor receptor 1 | Vascular endothelial growth factor | Fibroblast growth factor receptors
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 412 - 412
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2012, Volume 18, Issue 17, pp. 4682 - 4690
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2012, Volume 18, Issue 24, pp. 6658 - 6667
Journal Article
Cancer Discovery, ISSN 2159-8274, 2014, Volume 4, Issue 4, pp. 415 - 422
Journal Article
Cancer Discovery, ISSN 2159-8274, 02/2014, Volume 4, Issue 2, pp. 246 - 257
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2012, Volume 109, Issue 42, p. 17034
  Small cell lung cancer (SCLC) accounts for about 15% of all lung cancers. The prognosis of SCLC patients is devastating and no biologically targeted... 
Lung cancer | Genomics | Kinases | Cells | Cytoplasm | Tumors
Journal Article
04/2015
Stethoscope head cover (10) for covering a patient contacting site of a stethoscope head, the cover comprising: a ring-shaped mounting portion (11) for... 
SURGERY | DIAGNOSIS | HYGIENE | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES | IDENTIFICATION
Patent
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.